We are live on ! Find out more
FLAM

First Light Asset Management Portfolio holdings

AUM $1.12B
1-Year Est. Return 114.45%
This Fund
S&P 500
This Quarter Est. Return
-12.58%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$202M
AUM Growth
-$10.1M
Cap. Flow
+$30.2M
Cap. Flow %
14.92%
Top 10 Hldgs %
49.35%
Holding
66
New
5
Increased
31
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
ENTL
Entellus Medical, Inc. Common Stock
ENTL
+$5.4M
2
DOC
PHYSICIANS REALTY TRUST
DOC
+$4.95M
3
ATRC icon
AtriCure
ATRC
+$3.16M
4
MDCO
Medicines Co
MDCO
+$2.95M
5
ARWR icon
Arrowhead Research
ARWR
+$2.93M

Top Sells

Rank Stock Value
1
AMAG
AMAG Pharmaceuticals
AMAG
+$7.83M
2
NXTM
NxStage Medical Inc.
NXTM
+$3.38M
3
LAB icon
Standard BioTools
LAB
+$2.38M
4
VSTM icon
Verastem
VSTM
+$1.72M
5
ELGX
Endologix Inc
ELGX
+$1.68M

Sector Composition

Rank Sector Weight
1 Healthcare 83.82%
2 Energy 3.37%
3 Real Estate 2.4%
4 Financials 0.28%
5 Consumer Staples 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
1
AtriCure
ATRC
$1.92B
$19.7M 9.73%
899,362
+126,501
+16% +$3.16M
NEO icon
2
NeoGenomics
NEO
$1.96B
$17M 8.41%
2,971,545
+233,602
+9% +$1.45M
SRGA
3
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$11.3M 5.6%
66,540
+9,427
+17% +$1.81M
AKRX
4
DELISTED
Akorn Inc
AKRX
$9.25M 4.57%
324,480
+44,382
+16% +$1.83M
TEAR
5
DELISTED
TearLab Corporation
TEAR
$7.57M 3.74%
376,417
+74,630
+25% +$1.75M
HBIO icon
6
Harvard Bioscience
HBIO
$27.5M
$7.49M 3.7%
198,219
+27,417
+16% +$1.28M
ENZ
7
DELISTED
Enzo Biochem, Inc.
ENZ
$7.06M 3.49%
2,226,001
+786,671
+55% +$2.39M
OXFD
8
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$7.03M 3.47%
520,755
+72,390
+16% +$981K
LHCG
9
DELISTED
LHC Group LLC
LHCG
$6.83M 3.37%
152,441
+20,974
+16% +$921K
TLGT
10
DELISTED
Teligent, Inc
TLGT
$6.61M 3.27%
101,122
+13,026
+15% +$1.01M
OMCL icon
11
Omnicell
OMCL
$1.61B
$5.36M 2.65%
172,429
+25,508
+17% +$913K
INSM icon
12
Insmed
INSM
$21.4B
$5.06M 2.5%
272,393
+40,922
+18% +$1.02M
TECH icon
13
Bio-Techne
TECH
$11.2B
$5.02M 2.48%
217,144
+29,460
+16% +$739K
LGND icon
14
Ligand Pharmaceuticals
LGND
$5.76B
$4.93M 2.44%
92,286
+13,555
+17% +$822K
CYNA
15
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$4.89M 2.41%
302,194
+43,588
+17% +$708K
DOC
16
DELISTED
PHYSICIANS REALTY TRUST
DOC
$4.86M 2.4%
+321,979
New +$4.95M
LMAT icon
17
LeMaitre Vascular
LMAT
$2.32B
$4.59M 2.27%
376,211
+55,443
+17% +$711K
ARRY
18
DELISTED
Array Biopharma Inc
ARRY
$4.51M 2.23%
988,589
+139,215
+16% +$825K
ENTL
19
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$4.37M 2.16%
+242,532
New +$5.4M
QDEL icon
20
QuidelOrtho
QDEL
$1.14B
$3.8M 1.88%
201,067
+28,399
+16% +$607K
NXTM
21
DELISTED
NxStage Medical Inc.
NXTM
$3.79M 1.87%
240,229
-210,729
-47% -$3.38M
ALKS icon
22
Alkermes
ALKS
$8.22B
$3.76M 1.86%
64,148
+9,615
+18% +$635K
ANGO icon
23
AngioDynamics
ANGO
$611M
$3.66M 1.81%
277,323
+40,631
+17% +$613K
SPNC
24
DELISTED
Spectranetics Corp
SPNC
$3.37M 1.66%
285,596
+36,409
+15% +$652K
MDCO
25
DELISTED
Medicines Co
MDCO
$3.19M 1.58%
+84,103
New +$2.95M
1
2 3

Similar funds

AIM
Advyzon Investment Management Lisle, Illinois $1.12B AUM 22.08% 1-Year Est. Return
MTCM
Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return
CNC
Canandaigua National Corp Canandaigua, New York $1.12B AUM
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
RIM
Rockbridge Investment Management Syracuse, New York $1.11B AUM 13.62% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
HH
Hilltop Holdings Dallas, Texas $1.11B AUM 24.7% 1-Year Est. Return

First Light Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, First Light Asset Management held 66 positions worth $202M, down 4.7% from $212M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

First Light Asset Management deployed $30.2M of net new capital in Q3 2015, opening 5 new positions and adding to 31 existing holdings. Its largest new stake was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 82% a quarter earlier, followed by Energy and Real Estate.

On the sell side, the largest reduction was NxStage Medical Inc., an estimated $3.38M trimmed.

  • First Light Asset Management's largest Q3 2015 buy was Entellus Medical, Inc. Common Stock: 242,532 shares worth $4.37M.
  • First Light Asset Management added most to AtriCure in Q3 2015, an estimated $3.16M increase.
  • First Light Asset Management's biggest Q3 2015 reduction was NxStage Medical Inc., cutting an estimated $3.38M.
  • First Light Asset Management fully exited AMAG Pharmaceuticals in Q3 2015, selling an estimated $7.83M.
  • First Light Asset Management's ten largest holdings make up 49% of its $202M portfolio in Q3 2015.
  • First Light Asset Management opened 5 new positions and closed 4 in Q3 2015.
  • First Light Asset Management's portfolio value fell 4.7% quarter-over-quarter to $202M.

Based on First Light Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.